Crossmark

Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells

Crossref DOI link: https://doi.org/10.1186/s12935-019-1009-5

Published Online: 2019-12-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Jing

Zheng, Mingjun

Zhu, Liancheng

Deng, Lu

Li, Xiao

Gao, Linging

Wang, Caixia

Wang, Huimin

Liu, Juanjuan

Lin, Bei https://orcid.org/0000-0002-8881-9859
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81672590, 81472437)

Outstanding Scientific Fund of Shengjing Hospital (201804)
License Information

Text and Data Mining valid from 2019-12-01
More Information

Article History

Received: 28 June 2019

Accepted: 31 October 2019

First Online: 6 December 2019

Ethics approval and consent to participate

: Ethical approval was obtained from the Ethics Review Committee of China Medical University (the ethical approval code is 2010PS84K). 99 patients gave informed consent and agreed to participate in the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below